Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Agnieszka Badora

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Archives of Medical Science : AMS|May 22, 2015
The influence of steroid receptor status on the cardiotoxicity risk in HER2-positive breast cancer patients receiving trastuzumabJoanna Huszno, Agnieszka Badora, Elżbieta Nowara
ESMO Open|November 16, 2016
Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio before chemotherapy as potential prognostic factors in patients with newly diagnosed epithelial ovarian cancerAgnieszka Badora-Rybicka, Elżbieta Nowara, Danuta Starzyczny-Słota
Contemporary Oncology (Poznan, Poland)|April 5, 2017
Treatment related toxicity in BRCA1-associated epithelial ovarian cancer - is DNA repairing impairment associated with more adverse events?Agnieszka Badora-Rybicka, Magdalena Budryk, Elżbieta Nowara, et al.
Ginekologia Polska|November 27, 2013
[Multiple primary malignancies in BRCA1 mutation carriers--two clinical cases]Agnieszka Badora, Beata Kaleta, Elzbieta Nowara, et al.
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|September 27, 2019
Association of breast cancer grade with response to neoadjuvant chemotherapy assessed postoperativelyMichał Jarząb, Ewa Stobiecka, Agnieszka Badora-Rybicka, et al.
Journal of Contemporary Brachytherapy|March 2, 2022
Pre-operative high-dose-rate brachytherapy in early-stage cervical cancer: long-term single-center resultsSylwia Kellas-Ślęczka, Piotr Wojcieszek, Marta Szlag, et al.
Leukemia & Lymphoma|July 7, 2018
Hodgkin lymphoma of the elderly patients: a retrospective multicenter analysis from the Polish Lymphoma Research Group<sup>.</sup>Tomasz Wróbel, Przemysław Biecek, Justyna Rybka, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Archives of Medical Science : AMS|May 22, 2015
The influence of steroid receptor status on the cardiotoxicity risk in HER2-positive breast cancer patients receiving trastuzumabJoanna Huszno, Agnieszka Badora, Elżbieta Nowara
ESMO Open|November 16, 2016
Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio before chemotherapy as potential prognostic factors in patients with newly diagnosed epithelial ovarian cancerAgnieszka Badora-Rybicka, Elżbieta Nowara, Danuta Starzyczny-Słota
Contemporary Oncology (Poznan, Poland)|April 5, 2017
Treatment related toxicity in BRCA1-associated epithelial ovarian cancer - is DNA repairing impairment associated with more adverse events?Agnieszka Badora-Rybicka, Magdalena Budryk, Elżbieta Nowara, et al.
Ginekologia Polska|November 27, 2013
[Multiple primary malignancies in BRCA1 mutation carriers--two clinical cases]Agnieszka Badora, Beata Kaleta, Elzbieta Nowara, et al.
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|September 27, 2019
Association of breast cancer grade with response to neoadjuvant chemotherapy assessed postoperativelyMichał Jarząb, Ewa Stobiecka, Agnieszka Badora-Rybicka, et al.
Journal of Contemporary Brachytherapy|March 2, 2022
Pre-operative high-dose-rate brachytherapy in early-stage cervical cancer: long-term single-center resultsSylwia Kellas-Ślęczka, Piotr Wojcieszek, Marta Szlag, et al.
Leukemia & Lymphoma|July 7, 2018
Hodgkin lymphoma of the elderly patients: a retrospective multicenter analysis from the Polish Lymphoma Research Group<sup>.</sup>Tomasz Wróbel, Przemysław Biecek, Justyna Rybka, et al.
Pageof 1